Design Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Design Therapeutics

09/08/2021 22:56

* Design Therapeutics Inc  DSGN.OQ  reported a quarterly
adjusted loss of 14 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 18 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Design Therapeutics Inc's reported EPS for the quarter was a
loss of 14 cents​.
* The mean earnings estimate of analysts had fallen by
about 14.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Design Therapeutics Inc shares had fallen by 23.1% this
quarter.
* The company reported a quarterly loss of $7.64 million.
* Wall Street's median 12-month price target for Design
Therapeutics Inc is $36.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 09:56 p.m.  ​All
figures in US dollars unless otherwise stated